JARED MILLER: Open Payments
NPI 1891177333 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$766 in 38 payments from 9 companies in 2025. Trend: 2023 $590 · 2024 $756 · 2025 $766
Food & beverage: $766
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $167 |
| ABBVIE INC. | 10 | $137 |
| Neurocrine BioSciences, Inc. | 5 | $127 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $94 |
| Janssen Pharmaceuticals, Inc | 4 | $94 |
| Lundbeck LLC | 2 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| Noven Therapeutics, LLC | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: COBENFY, VRAYLAR, INGREZZA, REXULTI, CAPLYTA, INVEGA SUSTENNA, Secuado, AUSTEDO XR.
Industry payments across SC — which companies pay providers there.
